Changes in Outpatient Services and Medication Use Following a Non-fatal Opioid Overdose in the West Virginia Medicaid Program

Neel Koyawala, Rachel K. Landis, Colleen L. Barry, Bradley D. Stein, Brendan Saloner

ResearchPosted on rand.org Mar 12, 2019Published in: Journal of General Internal Medicine (2019). https://doi.org/10.1007/s11606-018-4817-8

West Virginia leads the USA in opioid overdoses, with a rate more than three times the national average. Post-overdose medications for opioid use disorder (MOUD) are protective against future deaths, yet are infrequently prescribed. Mental health disorders increase opioid overdose risk. Given the substantial burden of psychiatric comorbidities among people who overdose, it is important to understand how both MOUD and treatment for co-occurring mental health conditions change following overdoses.

Topics

Document Details

  • Publisher: Springer US  
  • Availability: Non-RAND
  • Year: 2019
  • Pages: 3
  • Document Number: EP-67811

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.